Body Revival Becomes First Ayurvedic Cancer Supplement to Complete Clinical Human Trial — A Milestone Led by Visionary CEO Munish Khan
Bridging Tradition with Evidence: Ayurveda Enters a New Era of Scientific Validation
Mumbai (Maharashtra) [India], March 29: In a remarkable achievement for Ayurveda and integrative healthcare, Health Reactive, under the leadership of its CEO Munish Khan, has successfully completed a Phase II human clinical trial of its flagship Ayurvedic formulation, Body Revival. The trial, registered under CTRI/2023/11/059465, marks a pivotal moment in India's traditional medicine history—bringing centuries-old Ayurvedic wisdom into the folds of modern evidence-based medicine.
The trial, conducted at the prestigious J. B. Roy State Ayurvedic Medical College & Hospital, Kolkata—India’s oldest Ayurvedic institution—focused on post-surgery breast cancer patients undergoing chemotherapy and radiotherapy. The 12-week randomized, controlled study demonstrated that Body Revival significantly improved Quality of Life (QoL), boosted Progression-Free Survival (PFS), and reduced the adverse effects associated with conventional cancer treatments.
The Visionary Behind the Breakthrough
This scientific leap would not have been possible without Munish Khan, CEO of Health Reactive, who dared to tread a path less taken. With a firm belief in Ayurveda backed by science, Khan initiated the clinical trial to transform Body Revival into an evidence-based therapeutic supplement. "In an era where people are increasingly looking for natural, safe, and effective healthcare options, it was vital to validate Ayurveda using rigorous clinical standards," Khan said.
His vision was not merely to create another herbal remedy, but to set a gold standard in Ayurvedic oncology support. The trial now positions Body Revival as one of the first Ayurvedic products in India to complete a human clinical study in collaboration with senior oncologists, Ayurvedic researchers, and government-recognized institutions.
Key Findings from the Clinical Trial
Conducted on 44 post-operative breast cancer patients, the trial divided subjects into four groups, with and without Body Revival alongside chemotherapy or radiation. The results were compelling:
- Enhanced physical and psychological well-being
- Reduced side effects like nausea, dizziness, fatigue, and muscle weakness
- Improved blood markers such as CA-15.3, hemoglobin, WBC, and liver enzymes
- Strengthened immune function and increased stamina
- Safe, well-tolerated and effective as an adjuvant therapy
Published at the 10th International World Ayurveda Congress in Dehradun, the findings drew attention from medical communities both in Ayurveda and allopathy.
Ayurveda Meets Modern Science
Body Revival is crafted from nine Ayurvedic herbs, including Aegle marmelos (Bael), Withania somnifera (Ashwagandha), Acorus calamus (Vacha), Blumea densiflora (Kakronda), Rubia cordifolia (Manjishtha), and Honey, among others. The formulation targets cellular detoxification, immune rejuvenation, and tissue repair.
In vitro studies, Body Revival displayed cytotoxic effects on MCF-7 breast cancer cells, inhibition of cancer cell migration and invasion, and downregulation of inflammatory markers. In silico analysis further confirmed its potential binding affinity with cancer-related receptors like HER2 and ER-α, validating its therapeutic value.
A Historic Moment for Evidence-Based Ayurveda
As the world seeks more integrative and holistic health approaches, this trial represents a turning point. It showcases how traditional systems can complement modern treatments—not as alternative, but as allies. By ensuring Body Revival adheres to global scientific standards, Health Reactive has made a case for Ayurveda on the international stage.
The company now aims to take this research to global medical practitioners, with plans to collaborate with oncologists, launch MRs (Medical Representatives), and expand clinical awareness across hospitals and healthcare networks.
Munish Khan’s initiative is more than a business endeavor—it is a mission to modernize and globalize Ayurveda. With the successful human trial of Body Revival, Health Reactive sets a precedent for Indian herbal sciences to be evaluated, respected, and adopted as part of mainstream, integrated care for serious diseases like cancer.